GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Capex-to-Operating-Income

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Capex-to-Operating-Income : 0.00 (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Cryofocus Medtech (Shanghai) Co's Capital Expenditure for the six months ended in Jun. 2023 was HK$-1.98 Mil. Its Operating Income for the six months ended in Jun. 2023 was HK$-55.76 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Cryofocus Medtech (Shanghai) Co Capex-to-Operating-Income Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Capex-to-Operating-Income Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
- - - -

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income falls into.


Cryofocus Medtech (Shanghai) Co Capex-to-Operating-Income Calculation

Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-7.828) / -135.518
=N/A

Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-1.982) / -55.757
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryofocus Medtech (Shanghai) Co  (HKSE:06922) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Cryofocus Medtech (Shanghai) Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Capex-to-Operating-Income
Comparable Companies
HKSE:02160 HKSE:01763 HKSE:09996 HKSE:06669 HKSE:02190 HKSE:02407 HKSE:01696 HKSE:02500 HKSE:02235 HKSE:02172 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120
Website
https://www.cryofocus.com
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines